Search Within

Eric J Sherman

Formats
  1. Meeting Abstract (187)
  2. Journal Article (141)
  3. Review (6)
  4. Correspondence (5)
  5. Editorial (3)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (346)
  2. Head and Neck Service (346)
  3. Solid Tumor Oncology Division (346)
  4. Radiation Oncology, Department of (203)
  5. Surgery (171)
  6. Head and Neck Surgery (169)

More Groups

People
  1. Nancy Lee (199)
  2. Nadeem Riaz (148)
  3. David Pfister (126)
  4. Sean McBride (111)
  5. Richard Wong (109)
  6. Alan Ho (88)

More People

Years
  1. 2025 (7)
  2. 2024 (36)
  3. 2023 (24)
  4. 2022 (29)
  5. 2021 (21)
  6. 2020 (38)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (94)
  2. Journal of Clinical Oncology (85)
  3. Annals of Oncology (19)
  4. Cancer (16)
  5. Head & Neck (16)
  6. Oral Oncology (8)

More Publications

Publishers
  1. Elsevier Inc. (110)
  2. American Society of Clinical Oncology (87)
  3. Oxford University Press (27)
  4. Wiley Blackwell (26)
  5. John Wiley & Sons, Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (346)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing outcomes after transoral robotic surgery for oropharyngeal carcinoma: Reflections on the ASCO guideline
    Correspondence

    Safavi, A. H.; Riaz, N.; Sherman, E. J.; Wong, R. J.; Lee, N. Y.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Response to letter to the editor from Zhang et al: "Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer"
    Correspondence

    Konda, B.; Sherman, E. J.; Massarelli, E.; Nieva, J.; Muzaffar, J.; Morris, J. C. 3rd; Ryder, M.; Ho, A. L.; Agulnik, M.; Wei, L.; more...
    Journal of Clinical Endocrinology and Metabolism (2025)

    Fulltext@MSK | Save
  • FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers
    Meeting Abstract

    Schreck, K. C.; De La Fuente, M. I.; Rine, J.; Kline, I.; Shephard, S. P.; Ahnert, J. R.; Sherman, E. J.; Yaeger, R.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
    Journal Article

    Xu, B.; Baine, M. K.; Jungbluth, A.; Alabkaa, A.; Serrette, R.; Roy, D.; Rudin, C. M.; Ho, A. L.; Sherman, E.; Dogan, S.; more...
    Journal of Clinical Endocrinology and Metabolism (2025)

    Fulltext@MSK | Save
  • Outcomes of reduced elective nodal radiation dose and volume for laryngeal, hypopharyngeal, and p16-negative oropharyngeal cancers
    Journal Article

    Zakeri, K.; Wren, S. D.; Shang, T.; Yu, Y.; Chen, L.; Shamseddine, A.; Safavi, A. H.; Kang, J. J.; Tsai, C. J.; Sherman, E. J.; more...
    Head & Neck (2025)

    Fulltext@MSK | Save
  • Long-term results of external beam radiation therapy with or without concurrent chemotherapy in differentiated thyroid cancer
    Journal Article

    Choi, J.; Sherman, E.; Dee, E. C.; Treechairusame, T.; Zakeri, K.; Kang, J. J.; Yu, Y.; Chen, L.; Shamseddine, A.; McBride, S. M.; more...
    Thyroid (2025)

    Fulltext@MSK | Save
  • Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer
    Journal Article

    Konda, B.; Sherman, E. J.; Massarelli, E.; Nieva, J.; Muzaffar, J.; Morris, J. C., III; Ryder, M.; Ho, A. L.; Agulnik, M.; Wei, L.; more...
    Journal of Clinical Endocrinology and Metabolism (2025)

    Fulltext@MSK | Save
  • Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
    Meeting Abstract

    Wong, W.; Sherman, E. J.; Kriplani, A.; Michel, L.; Zhi, I.; Hung, T. K. W.; Dunn, L.; Grewal, R. K.; Krishnamoorthy, G.; Ostrovnaya, I.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC
    Meeting Abstract

    Ho, A. L.; Riaz, N.; Pfister, D.; Wong, R.; Lee, N.; Sherman, E. J.; Haque, S.; Ostrovnaya, I.; Wong, W.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Cracchiolo, J.; Ho, A. L.; Sherman, E. J.; Ganly, I.; Ghossein, R.; Cohen, M.; Wong, W.; Desilets, A.; Michel, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save